Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 568.00
Bid: 564.00
Ask: 573.00
Change: -2.00 (-0.35%)
Spread: 9.00 (1.596%)
Open: 584.00
High: 584.00
Low: 563.00
Prev. Close: 570.00
GLE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

15 Nov 2021 07:00

RNS Number : 3039S
MJ Gleeson PLC
15 November 2021
 

MJ Gleeson plc

(GLE.L)

AGM Statement

 

MJ Gleeson plc (GLE.L), the low-cost housebuilder and land promoter, is holding its Annual General Meeting (AGM) at 11:30am today at the Grocers' Hall, London EC2R 8AD.

Dermot Gleeson, Chairman, will make the following comments:

"I am pleased to report that despite the widely reported challenges faced by the house building industry, including supply issues, increases in material & labour costs and planning delays, the business is performing well and the Board expects to deliver a result for the current year in line with market expectations.

Demand for Gleeson's low-cost homes remains strong and selling prices continue to increase, as planned. The average selling price on new reservations since the start of the financial year was 12% higher than in the same period last year.

Whilst the construction sector continues to experience availability and cost pressures with respect to labour and materials, Gleeson Homes has worked closely with its suppliers and subcontractors and has been able to continue building on all its sites.

Land continues to be available at sensible prices and the pipeline remains strong. Gleeson Homes has a land pipeline of 15,384 plots with a gross development value of £2.4 billion, of which 7,961 plots are owned and 7,423 are conditionally purchased.

The division currently has 82 active build sites, compared with 80 active build sites this time last year and is actively selling on 60 sites, compared with 65 sites this time last year. As a result of continued congestion in the planning system, not least as a result of a shortage of staff in council planning departments, there have been some delays to site acquisitions and site starts. With an improvement in the planning process we expect to acquire and open a total of 25 sites during the year to June 2022.

We expect Gleeson Homes to complete the sale of approximately 900 homes in the half year to 31 December 2021 and not less than 2,000 homes in the full year to 30 June 2022.

Strong demand driven by the structural need for more low-cost, high-quality homes for first time buyers and our ability to offer attractive levels of affordability to our customers, mean that the outlook for the division remains positive.

Gleeson Land continues to experience strong demand for consented land and has completed the sale of one site since the start of the financial year. Two sites are being actively progressed to sale, of which one site sale is expected to complete before 31 December 2021.

The issues with the planning system I referred to earlier have also delayed a number of site consents, but we expect these to be granted during the second half of the current financial year.

The division's land pipeline currently consists of 71 sites which have the potential to deliver approximately 22,000 plots. The portfolio includes 4 sites, with the potential to deliver 1,816 homes, which have planning permission or resolution to grant.

In conclusion, notwithstanding the challenges across our market, we are pleased with the progress in the year to date and remain confident that the result for the year to 30 June 2022 will be in line with market expectations."

 

15 November 2021

 

This announcement contains inside information. The person responsible for arranging the release of this announcement on behalf of the company is Stefan Allanson, Chief Financial Officer.

 

LEI: 21380064K7N2W7FD6434

 

Enquiries:

MJ Gleeson plc

 

Tel: +44 1142 612900

James Thomson

Chief Executive Officer

 

Stefan Allanson

Chief Financial Officer

 

 

 

 

 

 

 

Hudson Sandler

Tel: +44 20 7796 4133

Mark Garraway

Tel: +44 7771 860 938

 

 

Singer Capital Markets

 

Shaun Dobson

Tel: +44 20 7496 3000

Rachel Hayes

 

 

 

Liberum

 

Neil Patel

Tel: +44 20 3100 2222

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMGZMMMMFKGMZM
Date   Source Headline
14th Apr 202310:01 amRNSDirector/PDMR Shareholding
6th Apr 202311:13 amRNSDirector/PDMR Shareholding
5th Apr 20234:37 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSTotal Voting Rights
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSRe Directorate
21st Mar 20237:00 amRNSNotice of Capital Markets Day and Trading Update
13th Mar 20233:58 pmRNSSigning of the Self-Remediation Terms
8th Mar 20235:13 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSTotal Voting Rights
27th Feb 202312:05 pmRNSPerformance Share Plan award to Directors & PDMRs
16th Feb 20237:00 amRNSResults for the half-year ended 31 December 2022
8th Feb 20235:18 pmRNSCommittee appointments
8th Feb 20231:45 pmRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSTotal Voting Rights
13th Jan 20237:00 amRNSTrading Update & Notice of Results
6th Jan 20234:42 pmRNSDirector/PDMR Shareholding
3rd Jan 20237:00 amRNSRe Directorate
30th Dec 20227:00 amRNSTotal Voting Rights
15th Dec 202211:06 amRNSDirectorate External Appointments
12th Dec 20227:00 amRNSAppointment of Managing Director of Gleeson Land
8th Dec 20221:26 pmRNSDirector/PDMR Shareholding
30th Nov 20227:00 amRNSTotal Voting Rights
28th Nov 20223:46 pmRNSDirector/PDMR Shareholding
18th Nov 20221:05 pmRNSResult of AGM
18th Nov 20227:00 amRNSAGM Trading Update
8th Nov 202212:34 pmRNSDirector/PDMR Shareholding
4th Nov 20221:31 pmRNSDirector/PDMR Shareholding
1st Nov 20227:00 amRNSRe: Financial Calendar
31st Oct 20227:00 amRNSTotal Voting Rights
21st Oct 20224:21 pmRNSPerformance Share Plan award to Directors & PDMRs
20th Oct 20227:00 amRNSNotice of AGM
12th Oct 20227:00 amRNSRe Directorate
7th Oct 20224:41 pmRNSSecond Price Monitoring Extn
7th Oct 20224:36 pmRNSPrice Monitoring Extension
7th Oct 20221:25 pmRNSDirector/PDMR Shareholding
7th Oct 20227:00 amRNSRe Directorate External Appointments
5th Oct 20224:15 pmRNSExercise of Options & PDMR Dealing
3rd Oct 202211:55 amRNSDirector/PDMR Shareholding
30th Sep 20227:00 amRNSTotal Voting Rights
15th Sep 20227:00 amRNSFinal Results
7th Sep 20229:50 amRNSDirector/PDMR Shareholding
31st Aug 20227:00 amRNSTotal Voting Rights
9th Aug 20229:41 amRNSDirector/PDMR Shareholding
1st Aug 202211:28 amRNSNotification of Transaction by Directors/PCA
29th Jul 20227:00 amRNSTotal Voting Rights
14th Jul 20222:26 pmRNSDirector/PDMR Shareholding
11th Jul 20227:00 amRNSTrading Update & Notice of Results
7th Jul 20229:35 amRNSDirector/PDMR Shareholding
1st Jul 20227:05 amRNSMJ Gleeson achieves medium-term strategic target

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.